Acute heart failure following platinum and taxane-based chemotherapy for high grade ovarian cancer

Documenti analoghi

• Risk factors for chemotherapy‐induced peripheral neuropathy in patients receiving taxane‐ and platinum‐based chemotherapy
  di: Alex Molassiotis, et al.
  Pubblicazione: (2019-06-01)
• Patients with Advanced Ovarian Cancer Administered Oral Etoposide following Taxane as Maintenance Chemotherapy
  di: Hiroaki Nagano, et al.
  Pubblicazione: (2016-03-01)
• Desensitization in patients with hypersensitivity to platinum and taxane in gynecological cancers
  di: Tibor A. Zwimpfer, et al.
  Pubblicazione: (2024-01-01)
• Platinum drugs and taxanes: can we overcome resistance?
  di: Elena V. Sazonova, et al.
  Pubblicazione: (2021-06-01)
• TP53 status and taxane-platinum versus platinum-based therapy in ovarian cancer patients: A non-randomized retrospective study
  di: Markowska Janina, et al.
  Pubblicazione: (2008-01-01)